Enfusion

Enfusion OCF Margin

Delisted

The Operating Cash Flow Margin of Enfusion (ENFN) as of Nov 7, 2026 is 17.20 %. In the previous year, Operating Cash Flow Margin was 14.69 % — a change of 17.13% (higher).

OCF Margin

17.20 %

YoY

17.13%

Last updated:

Operating Cash Flow Margin of Enfusion is 2024 17.20 % . Operating Cash Flow Margin of Enfusion was 2023 14.69 % . It decreases by 17.13% higher compared to the previous year.

The Enfusion OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
20.85 USD
Jan 1, 2020
2.09 USD
Jan 1, 2021
-0.28 USD
Jan 1, 2022
9.42 USD
Jan 1, 2023
14.69 USD
Jan 1, 2024
17.20 USD
The Enfusion OCF Margin history
YEAROCF MarginYoY
17.20 %+17.13%
14.69 %+55.99%
9.42 %-3,407.24%
-0.28 %-113.60%
2.09 %-89.96%
20.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Operating Cash Flow Margin of Enfusion is 17.20 % in 2024.

Operating Cash Flow Margin of Enfusion changed from 14.69 % to 17.20 %, representing a 17.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Enfusion since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Enfusion

All Key Metrics — Enfusion